ADMA Biologics Inc (ADMA)

Number of days of payables

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Payables turnover 10.23 12.20 12.55 9.99 10.81 14.95 12.50 10.33 8.98 4.20 8.32 6.19 6.42 4.40 10.96 5.12 5.53 6.75 7.23 5.13
Number of days of payables days 35.67 29.91 29.08 36.55 33.77 24.41 29.20 35.35 40.64 86.86 43.87 58.92 56.87 82.99 33.31 71.28 65.95 54.07 50.51 71.18

December 31, 2024 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 10.23
= 35.67

Based on the data provided for ADMA Biologics Inc's number of days of payables from March 31, 2020, to December 31, 2024, the trend shows fluctuations in the company's payment cycle to its suppliers.

The number of days of payables ranged from as low as 24.41 days on September 30, 2023, to as high as 86.86 days on September 30, 2022, indicating varying levels of efficiency in managing payables. A lower number of days of payables suggests that the company is taking longer to pay its suppliers, which may strain relationships but can also indicate better cash flow management. Conversely, a higher number of days of payables could imply more favorable terms with suppliers but may also lead to liquidity challenges.

Overall, fluctuations in the number of days of payables over the period showcase the company's evolving payment practices and relationships with suppliers. Monitoring this metric can provide insights into ADMA Biologics Inc's working capital management and vendor relations strategy.